1	20 participation in other drug clinical trial within the last 2 month or receive an investigational drug within 5 half-lives of this other product whichever be long patient s who be know to have not take any dos of study drug s in early study y e.g screen-failures be allow without any time limitation|investigational drug[84,104]|||||||2 month[62,69]||C1875327|691729|691729|investigational drug
